Tunisian 216 Capital Invests in US-based eSteps
The startup, originally a university research project led by Nidhal Louhichi at the University of Bologna, developed a smart insole that detects early signs of neurodegenerative diseases.
Tunisian 216 Capital has invested in the US healthcare startup eSteps. The startup, originally a university research project led by Nidhal Louhichi at the University of Bologna, developed a smart insole that detects early signs of neurodegenerative diseases.
The insole tracks the user’s movements and gait, with data analyzed through a mobile app to offer personalized insights. This technology is also useful for athletes and fitness enthusiasts.
Founded as a startup in 2020, eSteps relocated its headquarters to Boston in March 2022 to be closer to the digital health hub. The company has since formed partnerships with healthcare organizations in the US and Europe. Supported by EXOR Ventures and 216 Capital, eSteps is expanding its reach, particularly in North Africa, with Tunisia as a key focus.
eSteps plans to continue developing products and services to offer a comprehensive connected health experience.
216 Capital, a Tunis-based venture capital firm founded in 2021, specializes in seed and pre-seed investments in technology companies.
